Home / Stocks / One Global Service Prov L
ONEGLOBAL

One Global Service Prov L Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹383.05

Change

-3.45 (-0.89%)

Open

₹386.5

Prev. Close

₹386.5

Day High

₹386.95

Day Low

₹377.8

Volume Analysis

Traded

10,266

Delivered

7,636

Delivery %

74.38%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Promoter holding is rising

Weaknesses (0)

No signal for this stock

Opportunities (3)

  • •Strong 3-year EPS growth (163.7%)
  • •Strong 3-year revenue growth (202.5%)
  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹396.55 ₹391.75 ₹387.4 ₹382.6 ₹378.25 ₹373.45 ₹369.1
Fibonacci ₹391.75 ₹388.25 ₹386.1 ₹382.6 ₹379.1 ₹376.95 ₹373.45
Camarilla ₹385.57 ₹384.73 ₹383.89 ₹382.6 ₹382.21 ₹381.37 ₹380.53

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

-1.48%

1 Month

-2.67%

3 Months

-30.99%

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

42.74%

Net margin 14.06% × asset turnover 1.9x × equity multiplier 1.6x

Company Overview

Sector

Healthcare

Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.

TopFund Analysis

One Global Service Prov L holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 67/100. The strongest factor is Financial Strength (100/100), while Cash Flow (8/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising. Strong 3-year EPS growth (163.7%).

TopFund Score — Fundamentals Quality

67/100 — Good

Data confidence: 72/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

100

Cash Flow

8

Corporate Governance

66

Institutional Ownership

45

Business Quality

82

Risk & Volatility

15

Liquidity

50

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Completed acquisition of 51% each in Matrix Labs Diagnocare and Matrix Labs Private on 12 Nov 2026.

Please find attached intimation regarding newspaper publication of Postal Ballot under regulation 30 & 47 of SEBI (LODR), 2015

Postal ballot for CMD remuneration/reappointment, loan-to-equity conversion, and independent director appointment; voting from 6 Nov to 5 Dec 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 (S) Dec 2023 (S) Mar 2024 (S) Jun 2024 (S) Sep 2024 (S) Dec 2024 (S) Mar 2025 (S) Jun 2025 (S) Sep 2025 (S) Dec 2025 (S) Mar 2026 (S) Jun 2026 (S) Sep 2026 (S)
Sales + 12 15 24 14 19 33 55 88 135 141 134 103 66
Expenses + 11 13 19 11 16 29 41 75 109 112 110 84 55
Operating Profit 1 2 5 2 3 5 15 13 26 29 24 19 11
OPM % 8.41% 13.82% 22.14% 17.4% 15.82% 14.41% 26.36% 15.07% 19.34% 20.51% 18.13% 18.66% 16.73%
Other Income + 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 1 2 5 2 3 5 15 13 26 29 24 19 11
Tax % 25.0% 25.13% 25.56% 24.57% 25.08% 27.04% 24.71% 25.04% 25.01% 25.12% 25.26% 25.01% 24.64%
Net Profit + 1 1 4 2 2 3 11 10 20 22 18 14 8
EPS in Rs 1 2 6 2 3 5 15 14 10 11 9 7 4
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 266 94 355 8 67 130 128 548 595 323 141 17 -51

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Sales + 0 0 0 0 2 0 4 6 18 63 147 498
Expenses + 0 0 0 0 2 0 1 5 16 53 122 405
Operating Profit 0 0 0 0 0 0 2 1 2 10 25 93
OPM % — — — 73.0% 14.0% — 68.0% 23.0% 9.0% 15.0% 17.0% 19.0%
Other Income + 0 0 0 0 0 0 0 0 0 0 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 1 1
Profit before tax 0 0 0 0 0 0 2 1 1 10 25 93
Tax % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -3.0% -1.0% 25.0% 26.0% 25.0%
Net Profit + 0 0 0 0 0 0 2 1 1 7 18 70
EPS in Rs 0 0 0 0 0 0 3 1 2 10 26 36
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 10.0% 0.0% 0.0%
Sales growth — — — — 627 -100 — 66 198 248 133 239

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S) Sep 2026 (S)
Reserves -5 -5 -5 -5 -4 -5 -2 -1 0 7 52 122 144
Borrowings + 0 0 0 1 0 0 0 0 0 0 0 0 0
Other Liabilities + 0 0 0 2 1 0 1 2 5 17 34 113 98
Total Liabilities 3 3 3 5 4 3 6 8 13 32 106 254 262
Fixed Assets + 0 0 0 0 0 0 1 1 1 1 2 2 2
CWIP 3 3 3 3 3 3 3 3 3 3 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 1
Other Assets + 0 0 0 2 1 0 3 5 9 28 104 252 260
Total Assets 3 3 3 5 4 3 6 8 13 32 106 254 262
Equity Capital 7 7 7 7 7 7 7 7 7 7 20 20 20

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Cash from Operating Activity + 0 0 0 0 0 0 1 1 0 1 14 -11
Cash from Investing Activity + 0 0 0 0 0 0 -1 -1 0 0 0 0
Cash from Financing Activity + 0 0 0 0 0 0 0 0 0 0 -1 0
Net Cash Flow 0 0 0 0 0 0 0 0 0 1 14 -11
Free Cash Flow 0 0 0 0 0 0 0 0 0 1 14 -11
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 90 162 111 -32 141 6 45 38 8 12 67 12

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 29.51% → 66.01%
  Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026 Oct 2026
Public 70.49% 62.52% 55.24% 55.53% 69.97% 69.98% 28.31% 26.16% 26.14% 23.87% 23.86% 27.11%
Promoters 29.51% 29.51% 29.51% 29.51% 15.05% 15.05% 66.24% 68.38% 68.4% 68.4% 68.4% 66.01%
FII 0.0% 7.97% 15.26% 14.98% 14.98% 14.98% 5.44% 5.45% 5.44% 7.72% 7.72% 6.86%
DII 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.01% 0.01% 0.01% 0.01%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
One Global Service Prov L (this stock) — — — —
Sun Pharmaceutical Ind L 451,075 36.7 5.05 16.0%
Divi S Laboratories Ltd 294,139 86.1 16.34 16.5%
Torrent Pharmaceuticals L 177,632 81.8 9.67 27.4%
Apollo Hospitals Enter. L 125,893 55.6 11.86 21.5%
Laurus Labs Limited 125,380 93.6 20.73 18.3%
Zydus Lifesciences Ltd 118,693 26.2 4.27 21.2%

Which Mutual Funds Hold One Global Service Prov L?

Frequently Asked Questions about One Global Service Prov L

Community Sentiment

What are other investors saying about One Global Service Prov L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.